tiprankstipranks
Caribou Biosciences initiates CB-010 GALLOP Phase 1 trial in lupus
PremiumThe FlyCaribou Biosciences initiates CB-010 GALLOP Phase 1 trial in lupus
2M ago
Caribou Biosciences price target lowered to $11 from $13 at BofA
Premium
The Fly
Caribou Biosciences price target lowered to $11 from $13 at BofA
3M ago
Caribou Biosciences price target raised to $34 from $26 at Brookline
Premium
The Fly
Caribou Biosciences price target raised to $34 from $26 at Brookline
3M ago
Caribou Biosciences price target lowered to $6 from $30 at Citi
PremiumThe FlyCaribou Biosciences price target lowered to $6 from $30 at Citi
4M ago
Caribou Biosciences Reports Q3 2024 Financial Results
Premium
Company Announcements
Caribou Biosciences Reports Q3 2024 Financial Results
4M ago
Caribou Biosciences reports Q3 EPS (38c), consensus (45c)
Premium
The Fly
Caribou Biosciences reports Q3 EPS (38c), consensus (45c)
5M ago
Caribou Biosciences Announces CFO Resignation and Succession Plan
PremiumCompany AnnouncementsCaribou Biosciences Announces CFO Resignation and Succession Plan
7M ago
Caribou Biosciences CFO Jason O’Byrne resigns
Premium
The Fly
Caribou Biosciences CFO Jason O’Byrne resigns
7M ago
Caribou Biosciences says FDA grants Fast Track designations to CB-010
Premium
The Fly
Caribou Biosciences says FDA grants Fast Track designations to CB-010
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100